Microbot Medical (MBOT) Trading 0% Higher

Microbot Medical Inc (NASDAQ:MBOT)’s share price traded up 0% on Wednesday . The company traded as high as $1.13 and last traded at $1.09. 2,569,223 shares were traded during mid-day trading, an increase of 59% from the average session volume of 1,616,912 shares. The stock had previously closed at $1.09.

In other Microbot Medical news, Director Moshe Shoham sold 33,700 shares of the company’s stock in a transaction dated Monday, October 9th. The stock was sold at an average price of $1.50, for a total value of $50,550.00. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Also, Director Yoseph Bornstein sold 42,132 shares of the company’s stock in a transaction dated Tuesday, January 2nd. The stock was sold at an average price of $1.01, for a total value of $42,553.32. The disclosure for this sale can be found here. Insiders sold a total of 421,690 shares of company stock worth $489,344 over the last 90 days. Corporate insiders own 31.83% of the company’s stock.

An institutional investor recently bought a new position in Microbot Medical stock. Sabby Management LLC acquired a new stake in shares of Microbot Medical Inc (NASDAQ:MBOT) during the 2nd quarter, according to its most recent filing with the SEC. The institutional investor acquired 1,285,351 shares of the biotechnology company’s stock, valued at approximately $1,825,000. Sabby Management LLC owned about 2.92% of Microbot Medical at the end of the most recent quarter. Institutional investors and hedge funds own 4.66% of the company’s stock.

TRADEMARK VIOLATION NOTICE: “Microbot Medical (MBOT) Trading 0% Higher” was originally posted by Transcript Daily and is the property of of Transcript Daily. If you are reading this report on another website, it was copied illegally and republished in violation of U.S. & international copyright & trademark legislation. The legal version of this report can be read at https://transcriptdaily.com/2018/01/05/microbot-medical-mbot-trading-0-higher.html.

Microbot Medical Company Profile

Microbot Medical Inc, formerly StemCells, Inc, is a medical device company. The Company specializes in the researching, designing, developing and commercializing transformational micro-robotic medical technologies leveraging the artificial and natural lumens within the human body. It is engaged in developing its two product candidates: the Self Cleaning Shunt (SCS) for the treatment of hydrocephalus and normal pressure hydrocephalus (NPH), and TipCAT, a self-propelling, semi-disposable endoscope that the Company is developing for use in colonoscopy procedures.

Receive News & Ratings for Microbot Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Microbot Medical and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply